
Currently out of the existing stock ratings of David Maris, 54 are a BUY (47.37%), 48 are a HOLD (42.11%), 12 are a SELL (10.53%).
Analyst David Maris, has had 49.23% of price targets met with an average potential upside of 18.19%, reached in 285 days on average. Previously, David Maris worked at WELLS FARGO, BMO.
David Maris has documented 219 price targets and ratings displayed on 20 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 27-Oct-2021.
Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for TEVA (TEVA PHARMA INDUSTRIES LTD ADR) on 10/28/2021. The price target of $10 was fulfilled within 5 days with a profit of $1.27 (14.55%), with a performance score of 29.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Dec-2016
$193
$202
6 years 6 months 29 days ago
(21-Apr-2020)
4/12 (33.33%)
$8.96 (4.87%)
141
Hold Since 08-May-2019
$203
$178
6 years 9 months 9 days ago
(10-Feb-2020)
5/19 (26.32%)
$4.87 (2.46%)
74
Buy Since 03-Aug-2017
$198
$184
6 years 9 months 28 days ago
(22-Jan-2020)
5/14 (35.71%)
$7.8 (4.10%)
134
Buy Since 03-Aug-2015
$200
7 years ago
(19-Nov-2019)
2/12 (16.67%)
$73.92 (58.63%)
290
Hold Since 19-Nov-2019
$203
$189
7 years ago
(19-Nov-2019)
1/2 (50%)
$19.19 (10.44%)
96